Amylin Pharmaceuticals Inc (NASDAQ:AMLN) to Release Q1 2008 Earnings April 21

Amylin Pharmaceuticals Inc (NASDAQ:AMLN) will release the first quarter earnings for 2008 on Monday, April 21.  The financial results will be made available at investors.amylin.com.

A biopharmaceutical company, Amylin Pharmaceuticals is engage din the discovery, development and commercialization of drug candidates to treat diabetes, obesity and other diseases.  The company markets two first in class diabetes medication treatments, BYETTA injection and SYMLIN injection.

Amylin works with Eli Lilly and company and Alkermes, Inc., in the development of exenatide once weekly.  It also maintains and active discovery research program, focusing on peptide therapeutics and actively seeks in-license additional drug candidates.

Find more Earnings related events on Finditt Events.